Clinical Trial Update: MOTIV BTK Randomized Controlled Trial [NA]

View source ↗

Summary

The document notes a MOTIV BTK randomized controlled trial sponsored by REVA Medical, Inc. that is currently recruiting for Critical Limb Ischemia, with no phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• MOTIV BTK

Snippet

Sponsor: REVA Medical, Inc. | Conditions: Critical Limb Ischemia | NA | Status: RECRUITING